Arlene Morris - 01 Jul 2025 Form 4 Insider Report for Viridian Therapeutics, Inc.\DE (VRDN)

Role: Director
Signature: /s/ Jennifer Tousignant, Attorney-in-fact
Issuer symbol: VRDN
Transactions as of: 01 Jul 2025
Net transactions value: $0
Form type: 4
Filing time: 02 Jul 2025, 16:45:26 UTC
Previous filing: 18 Jun 2025
Next filing: 11 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Morris Arlene	Director	C/O VIRIDIAN THERAPEUTICS, INC., 221 CRESCENT STREET, SUITE 103A, WALTHAM	/s/ Jennifer Tousignant, Attorney-in-fact	02 Jul 2025	0001362520

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VRDN	Stock Option (Right to Buy)	Award	$0	+21,000		$0.000000	21,000	01 Jul 2025	Common Stock	21,000	$14.47	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests in full upon the earlier to occur of (i) July 1, 2026 or (ii) the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continued service on the Board of Directors of the Issuer.